The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains ; volume:20 ; number:1 ; day:11 ; month:2 ; year:2020 ; pages:1-8 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (11.2.2020), 1-8, 12.2020
- Creator
-
Li, Shengjia
Ouyang, Jinming
Zhao, Bin
An, Minghui
Wang, Lin
Ding, Haibo
Zhang, Min
Han, Xiaoxu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-020-4836-z
- URN
-
urn:nbn:de:101:1-2020051105521191988158
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Shengjia
- Ouyang, Jinming
- Zhao, Bin
- An, Minghui
- Wang, Lin
- Ding, Haibo
- Zhang, Min
- Han, Xiaoxu
- SpringerLink (Online service)
Other Objects (12)
Can Infinitists Handle the Finite Mind Objection and the Distinction Objection?
A Dilemma for Globalized Safety
Knowledge from Falsehood, Ignorance of Necessary Truths, and Safety
Numerical optimization of electromagnetic components
Single-Valley-Extended Continuous Solutions For The Feigenbaum’S Functional Equation ƒ(ϕ(x))=ϕ 2 (f (x))
la...de la mémoire : Silhouetten für zwölf Instrumente (Fragm.)
Jawohl "Herr Präsident"! I am here!! : 2005
Das Rätsel der Begierde
Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy
Improving the Electrical Contact Property of Single-Walled Carbon Nanotube Arrays by Electrodeposition
Can Infinitists Handle the Finite Mind Objection and the Distinction Objection?
A Dilemma for Globalized Safety
Knowledge from Falsehood, Ignorance of Necessary Truths, and Safety
Numerical optimization of electromagnetic components
Single-Valley-Extended Continuous Solutions For The Feigenbaum’S Functional Equation ƒ(ϕ(x))=ϕ 2 (f (x))
la...de la mémoire : Silhouetten für zwölf Instrumente (Fragm.)
Jawohl "Herr Präsident"! I am here!! : 2005
Das Rätsel der Begierde
Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy
Improving the Electrical Contact Property of Single-Walled Carbon Nanotube Arrays by Electrodeposition
Can Infinitists Handle the Finite Mind Objection and the Distinction Objection?
A Dilemma for Globalized Safety
Knowledge from Falsehood, Ignorance of Necessary Truths, and Safety
Numerical optimization of electromagnetic components
Single-Valley-Extended Continuous Solutions For The Feigenbaum’S Functional Equation ƒ(ϕ(x))=ϕ 2 (f (x))
la...de la mémoire : Silhouetten für zwölf Instrumente (Fragm.)
Jawohl "Herr Präsident"! I am here!! : 2005
Das Rätsel der Begierde
Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy